사람구강편평상피암세포에서 유지놀에 의한 세포자멸사 유도 효과
The effect of eugenol on the induction of apoptosis in HSC-2 human oral squamous cell carcinoma
0
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Objectives: Oropharynx tumors(oral cancer), are caused by tobacco, alcohol consumption, and high-risk human papillomavirus(HPV) infection. Oral squamous cell carcinoma(OSCC) is the most common type of oral cancer and frequently arises from the mucosa of the oropharynx and oral cavity. Despite advances in the diagnosis and treatment(chemotherapy, radiotherapy, and surgery) of oral cancer, over the past two decades, the overall survival rates remains at about 60%. Methods: We pretreated HSC-2 cells with various doses of exposed the cells to eugenol and then we measured cell viability by MTT assay. Results: Cell proliferation was markedly inhibited after eugenol treatment compared to the control. The majority of HSC-2 cells in the control groups showed normal morphology with round regular nuclei. In contrast, apoptotic bodies were seen in the 0.5 mM, 1 mM, 2 mM group. However, the pretreatment with eugenol increased HSC-2 cells apoptosis according to dose-dependency. PI staining quantitatively confirmed the anti-apoptotic effects of propofol. The expression levels of cleaved caspase 3, and Bak significantly increased in HSC-2 cells. Conclusions: These findings indicate that eugenol could be a potential anti-cancer agent for human OSCC and provide valuable data for the development of a novel anticancer strategy.
Abstract
Objectives: Oropharynx tumors(oral cancer), are caused by tobacco, alcohol consumption, and high-risk human papillomavirus(HPV) infection. Oral squamous cell carcinoma(OSCC) is the most common type of oral cancer and frequently arises from the mucosa of the oropharynx and oral cavity. Despite advances in the diagnosis and treatment(chemotherapy, radiotherapy, and surgery) of oral cancer, over the past two decades, the overall survival rates remains at about 60%. Methods: We pretreated HSC-2 cells with various doses of exposed the cells to eugenol and then we measured cell viability by MTT assay. Results: Cell proliferation was markedly inhibited after eugenol treatment compared to the control. The majority of HSC-2 cells in the control groups showed normal morphology with round regular nuclei. In contrast, apoptotic bodies were seen in the 0.5 mM, 1 mM, 2 mM group. However, the pretreatment with eugenol increased HSC-2 cells apoptosis according to dose-dependency. PI staining quantitatively confirmed the anti-apoptotic effects of propofol. The expression levels of cleaved caspase 3, and Bak significantly increased in HSC-2 cells. Conclusions: These findings indicate that eugenol could be a potential anti-cancer agent for human OSCC and provide valuable data for the development of a novel anticancer strategy.
참고문헌 (26)
- Chen SF, "Reappraisal of the anticancer efficacy of quercetin in oral cancer cells", J Chin Med Assoc, 76(3), pp.146~152 (2013)
- Zhang X, "A lymph node metastatic mouse model reveals alterations of metastasis-related gene expression in metastatic human oral carcinoma sublines selected from a poorly metastatic parental cell line", Cancer, 95(8), pp.1663~1672 (2002)[DOI]
- Chen YJ, "Head and neck cancer in the betel quid chewing area: recent advances in molecular carcinogenesis", Cancer Sci, 99(8), pp.1507~1514 (2008)[DOI]
- Adelstein DJ, "An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer", J Clin Oncol, 21(1), pp.92~98 (2003)[DOI]
- Boulikas T, "Recent clinical trials using cisplatin, carboplatin and their combination chemotherapy drugs (review)", Oncol Rep, 11(3), pp.559~595 (2004)[DOI]
- Butler MS, "The role of natural product chemistry in drug discovery", J Nat Prod, 67(12), pp.2141~2153 (2004)[DOI]
- Sondak VK, "Allogeneic and autologous melanoma vaccines: where have we been and where are we going?", Clin Cancer Res, 12(7 Pt 2), pp.2337s~2341s (2006)[DOI]
- Pramod K, "Eugenol: a natural compound with versatile pharmacological actions", Nat Prod Commun, 5(12), pp.1999~2006 (2010)
- Stich HF, "Potentiation of genotoxicity by concurrent application of compounds found in betel quid: arecoline, eugenol, quercetin, chlorogenic acid and Mn2+", Mutat Res, 90(4), pp.355~363 (1981)[DOI]
- Benencia F, "In vitro and in vivo activity of eugenol on human herpesvirus", Phytother Res, 14(7), pp.495~500 (2000)[DOI]
- Ibtehaj Al-Sharif, "Eugenol triggers apoptosis in breast cancer cells through E2F1", survivin down-regulation, 2013, pp.13(1), 600~[DOI]
- Park BS, "Phospho-ser 15-p53 translocates into mitochondria and interacts with Bcl-2 and Bcl-xL in eugenol-induced apoptosis", Apoptosis, 10(1), pp.193~200 (2005)[DOI]
- Slamenova D, "Investigation of anti-oxidative, cytotoxic, DNA-damaging and DNA-protective effects of plant volatiles eugenol and borneol in human-derived HepG2, Caco-2 and VH10 cell lines", Mutat Res, 677(1-2), pp.46~52 (2009)[DOI]
- Okada N, "Induction of cytotoxicity and apoptosis and inhibition of cyclooxygenase-2 gene expression by eugenol -related compounds", Anticancer Res, 25(5), pp.3263~3269 (2005)
- Ghosh R, "Eugenol causes melanoma growth suppression through inhibition of E2F1 transcriptional activity", The Journal of biological chemistry, 280(7), pp.5812~5819 (2005)[DOI]
- Pisano M, "Antiproliferative and pro-apoptotic activity of eugenol-related biphenyls on malignant melanoma cells", Mol Cancer, (6), pp.8~ (2007)
- 이아름, "코엔자임 Q10 처리에 따른 TEGDMA에 의해 유발된 치아세포 사멸 억제 효과", 한국치위생학회지, 14(5), pp.775~781 (2014), 한국치위생학회[DOI]
- 허만규, "연잎 추출물의 구강미생물에 대한 항균 효과", 한국치위생학회지, 14(1), pp.117~122 (2014), 한국치위생학회[DOI]
- Chen PN, "Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway", J Dent Res, 85(3), pp.220~225 (2006)[DOI]
- Siegel R, "Cancer statistics, 2012", CA Cancer J Clin, 62(1), pp.10~29 (2012)[DOI]
- Parkin DM, "Global cancer statistics, 2002", CA Cancer J Clin, 55(2), pp.74~108 (2005)[DOI]
- Schneider-Stock R, "High prognostic value of p16INK4 alterations in gastrointestinal stromal tumors", J Clin Oncol, 21(9), pp.1688~1697 (2003)[DOI]
- Adams JM, "Bcl-2-regulated apoptosis: mechanism and therapeutic potential", Curr Opin Immunol, 19(5), pp.488~496 (2007)[DOI]
- Jaganathan SK, "Antiproliferative and molecular mechanism of eugenol-induced apoptosis in cancer cells", Molecules, 17(6), pp.6290~6304 (2012)[DOI]
- Yoo CB, "Eugenol isolated from the essential oil of Eugenia caryophyllata induces a reactive oxygen species-mediated apoptosis in HL-60 human promyelocytic leukemia cells", Cancer Lett, 225(1), pp.41~52 (2005)[DOI]
- Kaur G, "Eugenol precludes cutaneous chemical carcinogenesis in mouse by preventing oxidative stress and inflammation and by inducing apoptosis", Mol Carcinog, 49(3), pp.290~301 (2010)[DOI]